共 75 条
[1]
Aiuti A., Cattaneo F., Galimberti S., Benninghoff U., Cassani B., Callegaro L., Scaramuzza S., Andolfi G., Mirolo M., Brigida I., Tabucchi A., Carlucci F., Eibl M., Aker M., Slavin S., Al-Mousa H., Al Ghonaium A., Ferster A., Duppenthaler A., Notarangelo L., Wintergerst U., Buckley R.H., Bregni M., Marktel S., Valsecchi M.G., Rossi P., Ciceri F., Miniero R., Bordignon C., Roncarolo M.G., Gene therapy for immunodeficiency due to adenosine deaminase deficiency, N Engl J Med, 360, pp. 447-458, (200
[2]
Appleton A.L., Curtis A., Wilkes J., Cant A.J., Differentiation of materno-fetal GVHD from Omenn's syndrome in pre-BMT patients with severe combined immunodeficiency, Bone Marrow Transplant, 14, pp. 157-159, (1994)
[3]
Benke P.J., Dittmar D., Purine dysfunction in cells from patients with adenosine deaminase deficiency, Pediatr Res, 10, pp. 642-646, (1976)
[4]
Berrington J.E., Flood T.J., Abinun M., Galloway A., Cant A.J., Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency, Archives of Disease in Childhood, 82, 2, pp. 144-147, (2000)
[5]
Bertrand Y., Muller S.M., Casanova J.L., Morgan G., Fischer A., Friedrich W., Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients, Bone Marrow Transplant, 29, pp. 759-762, (2002)
[6]
Blaese R.M., Culver K.W., Miller A.D., Carter C.S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., Greenblatt J.J., Rosenberg S.A., Klein H., Berger M., Mullen C.A., Ramsey W.J., Muul L., Morgan R.A., Anderson W.F., T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years, Science, 270, pp. 475-480, (1995)
[7]
Borghans J.A., Bredius R.G., Hazenberg M.D., Roelofs H., Jol-Van D.Z.E.C., Heidt J., Otto S.A., Kuijpers T.W., Fibbe W.E., Vossen J.M., Miedema F., Van Tol M.J., Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency, Blood, 108, 2, pp. 763-769, (2006)
[8]
Brown L., Xu-Bayford J., Allwood Z., Slatter M., Cant A., Davies E.G., Veys P., Gennery A.R., Gaspar H.B., Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: The case for newborn screening, Blood, 117, 11, pp. 3243-3246, (2011)
[9]
Buck D., Malivert L., De Chasseval R., Barraud A., Fondaneche M.-C., Sanal O., Plebani A., Stephan J.-L., Hufnagel M., Le D.F., Fischer A., Durandy A., De Villartay J.-P., Revy P., Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly, Cell, 124, 2, pp. 287-299, (2006)
[10]
Cavazzana-Calvo M., Carlier F., Le Deist F., Morillon E., Taupin P., Gautier D., Radford-Weiss I., Caillat-Zucman S., Neven B., Blanche S., Cheynier R., Fischer A., Hacein-Bey-Abina S., Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype, Blood, 109, pp. 4575-4581, (2007)